Depomed, Inc. ( NASDAQ:DEPO ) announced today that the previously announced product license agreement under which Solvay Pharmaceuticals will have exclusive rights for DM-1796 for the treatment of pain in the United States, Canada, Mexico and Puerto ...
Original post: Depomed’s License Agreement With Solvay Pharmaceuticals Clears HSR ... - Genetic Engineering News
- Recent posts
- Adolor Corporation Announces Management Appointments - Earthtimes
- Doctor on Probation for Prescribing Excessive Pain Medication - WOWK
- Depomed’s License Agreement With Solvay Pharmaceuticals Clears HSR ... - Genetic Engineering News
- Pain Management Class 2009 | How To Cope With Pain Blog
- Pain Management Might Be The Solution For Your Chronic Back Pain...
- Endo Shifts Gears With Indevus - Forbes
- Stolen marijuana reported - Evansville Courier-Press
- Biovail voluntarily recalls certain lots of Ultram ER 100mg tablets ... - RTT News
- Naprapathy: A Hands-On Approach to Pain Management - Health News ...
- Why acupuncture? - Fort Lauderdale Sun-Sentinel
- Some Hawaii islands short on physicians - Honolulu Advertiser
- Getting ahead - Missoulian
- [ Pain& Pain Management ] Open Question : what do IVs really do?
- Resistance training eases low back pain: study - HealthCentral.com
- Causes Of Joint Pain - Pain Management Articles - ArticleDoctor.com
- Piramal Healthcare Limited to Acquire Minrad International, Inc. - Earthtimes
- Toyota projects 1st ever operating loss for year - Seattle Post Intelligencer
- Frizzy2008 Tips: Maintaining Intimacy in Pain Management
- Ideas Behind Pain Management - Pain Management Articles ...
- 'The History of Howard Stern Act II' to Air Exclusively on SIRIUS XM ... - Earthtimes